National Peroxide Limited (500298) Fair Value & Analysis
Other · IN · Market cap ₹11.3B
Fair value as of: Jul 4, 2026
From 17 valuation models · updated today
Share price +12.7% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹499.25 – ₹1,161 · fair‑value band ₹63.60 – ₹237.97 · the ₹661.40 price screens above the ₹110.38 fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
National Peroxide Limited (500298) currently trades at ₹661.40, while our model-based Fair Value estimate is ₹110.38 — implying the stock looks roughly 83.3% overvalued today. We read business quality at 42/100 (below-average quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, National Peroxide Limited generated revenue of ₹1.6B at a net margin of 11.0%. Revenue declined 1.7% year over year. It earns a return on equity of 1.6%. Net debt stands at ₹74.6M. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
National Peroxide Limited manufactures and sells peroxygens in India. It offers hydrogen peroxide that is used in various industries for chemical synthesis, textile bleaching, paper pulp bleaching, sugar bleaching, non-edible oil bleaching, water and effluent treatment, metallurgy, environmental control, sterilization, and other applications. The company also provides compressed hydrogen gas and per acetic acid; and engages in the investment activities. National Peroxide Limited was founded in 1954 and is headquartered in Mumbai, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
National Peroxide Limited reported revenue of ₹267M in FY2026 versus ₹2.3B in FY2022, a compound −41.4%/yr. Reported net income was ₹107M in FY2026, compounding +18.5%/yr from FY2022.
Is 500298 fairly valued? → Check now
Similar stocks
6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| There MOH | €521.90 | €209.16 | -60% |
| Sony Corporation SON1 | €17.58 | €39.38 | +124% |
| Federal Home Loan Mortgage Corporation FREJO | $16.84 | $28.75 | +71% |
| 533278 533278 | ₹438.60 | ₹720.31 | +64% |
| Nestl?? India Limited 500790 | ₹1,459 | ₹279.60 | -81% |
| 540376 540376 | ₹3,993 | ₹1,806 | -55% |
Explore undervalued stocks
Frequently asked questions
Is National Peroxide Limited (500298) undervalued?
What is the fair value of 500298?
What is the quality score of 500298?
What is the revenue of National Peroxide Limited (500298)?
What is the net profit margin of 500298?
Does National Peroxide Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.